An animal model of pulmonary infection after single lung transplantation.
Kim
H K
HK
Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Tazelaar
H D
HD
Odell
J
J
Park
Y S
YS
Steckelberg
J M
JM
Miller
V M
VM
McGregor
C G
CG
D000704:Analysis of Variance; D000818:Animals; D002437:Cefazolin / Q000627:therapeutic use; D002981:Clindamycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004195:Disease Models, Animal; D004285:Dogs; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004927:Escherichia coli Infections / Q000473:pathology / Q000503:physiopathology* / Q000517:prevention & control; D005839:Gentamicins / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016040:Lung Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D008297:Male; D009504:Neutrophils / Q000473:pathology; D018410:Pneumonia, Bacterial / Q000473:pathology / Q000503:physiopathology* / Q000517:prevention & control; D011183:Postoperative Complications; D011650:Pulmonary Alveoli / Q000473:pathology; D014184:Transplantation, Homologous
D005839:Gentamicins; D007166:Immunosuppressive Agents; D002981:Clindamycin; C007084:clindamycin phosphate; D002437:Cefazolin